| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash | 6.91 | 0.05 | 4.69 | 5.11 |
| Receivables | 14.01 | 5.40 | 4.25 | 3.70 |
| Inventory | — | — | — | — |
| Other | 4.90 | — | — | — |
| 27.39 | 5.47 | 10.04 | 9.58 |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Payables | 3.22 | — | 2.79 | 3.32 |
| ST’ Debt | 3.55 | — | — | 0.66 |
| Other | 3.11 | — | 0.04 | 0.01 |
| 24.12 | 0.06 | 3.81 | 4.85 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡ | ‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
8.71
|
| ’24 | — | — | — | — |
1.44
|
| ’23 | — | — | — | — |
0.28
|
| ’22 | — | 2.58 | — | 2.93 |
5.51
|
| ’21 | — | 4.49 | — | 5.16 |
9.64
|
| ’20 | — | 6.23 | — | 8.30 |
14.53
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | 1.11 | — | (0.52) |
(0.52)
|
| ’24 | — | 1.32 | — | (4.25) |
3.25
|
| ’23 | — | (2.46) | — | (2.72) |
(2.72)
|
| ’22 | — | (3.99) | — | (5.23) |
(5.22)
|
| ’21 | — | — | — | (7.54) |
(7.54)
|
| ’20 | — | (1.25) | — | 1.53 |
1.53
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | 1.11 | — | (0.52) |
(0.52)
|
| ’24 | — | 0.57 | — | (5.02) |
2.48
|
| ’23 | — | (2.46) | — | (2.72) |
(2.72)
|
| ’22 | — | (3.99) | — | (5.24) |
(5.69)
|
| ’21 | — | — | — | (7.65) |
(9.69)
|
| ’20 | — | (2.17) | — | 1.43 |
(1.71)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
(7.13)
|
| ’24 | — | — | — | — |
(1.05)
|
| ’23 | — | (1.03) | — | — |
(6.55)
|
| ’22 | — | (38.04) | — | (5.66) |
(2.12k)
|
| ’21 | — | (6.93) | — | (7.81) |
(2.36k)
|
| ’20 | — | 0.29 | — | 0.48 |
840.00
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | ‡‡‡‡‡ | 440.80 | 6.64 | 1.63 | 0.88 | — | — | — |
Low Price
|
| — | — | — | — | — | ‡‡‡‡‡ | 5,120.00 | 1,360.00 | 54.64 | 2.65 | — | — | — |
High Price
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 214 | 11 | 55 | 48 | — | — | — |
Employees
|
| — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.03 | 0.03 | 0.03 | 0.18 | — | — | — |
Revenue/Emp
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.51 | 0.28 | 1.44 | 8.71 | — | — | — |
Revenue
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.93% | 55.25% | 41.22% | 29.50% | — | — | — |
Gross Margin
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.54) | (21.44) | (2.08) | (57.20) | — | — | — |
EBT
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (46.05%) | (7,656.71%) | (144.63%) | (657.00%) | — | — | — |
EBT Margin
|
| — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.54) | (21.44) | (2.10) | (57.20) | — | — | — |
Net Income
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.66 | — | 0.11 | 0.41 | — | — | — |
Depreciation
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 764.68 | 0.71 | 0.72 | 1.09 | — | — | — |
Revenue/Sh
|
| — | — | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,120.00) | (6.55) | (1.05) | (7.13) | — | — | — |
Earnings/Sh
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (725.54) | (6.90) | 1.63 | (0.07) | — | — | — |
Cash Flow/Sh
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (65.39) | 0.00 | (0.39) | 0.00 | — | — | — |
Capex/Sh
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (790.93) | (6.90) | 1.24 | (0.07) | — | — | — |
Free CF/Sh
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 903.01 | 146.17 | 33.47 | 2.27 | — | — | — |
Book Value/Sh
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.01 | 0.39 | 2.00 | 8.02 | — | — | — |
Shares
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 48.34 | 3.23 | 0.66 | 0.28 | — | — | — |
PS Ratio
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 112.61 | 0.85 | 0.15 | 0.23 | — | — | — |
PB Ratio
|
| — | — | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 48.12 | 3.46 | 0.61 | (0.01) | — | — | — |
EV/Sales
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (47.04) | (3.58) | (0.95) | 0.04 | — | — | — |
EV/FCF
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.22) | (2.72) | 3.25 | (0.52) | — | — | — |
Op' Cash Flow
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.47) | — | (0.77) | — | — | — | — |
Capex
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.69) | (2.72) | 2.48 | (0.52) | — | — | — |
FCF
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.27 | 5.40 | 6.23 | 4.73 | — | — | — |
Working Cap'
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.58 | — | 0.31 | 0.77 | — | — | — |
Total Debt
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.34) | (0.05) | (4.39) | (4.35) | — | — | — |
Net Debt
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.50 | 57.59 | 66.80 | 18.20 | — | — | — |
Sh' Equity
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (51.64%) | (5.84%) | (3.19%) | (117.99%) | — | — | — |
ROA
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.73%) | (3.43%) | (1.74%) | (254.50%) | — | — | — |
ROIC
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (136.30%) | (8.04%) | (3.37%) | (134.55%) | — | — | — |
ROE
|
Infobird Co., Ltd. (IFBD), a microcap AI-driven CRM SaaS provider focused on China’s volatile market, has endured a brutal boom-and-bust cycle since its 2021 SPAC debut on Nasdaq. Revenue peaked at $18.25 million in 2019 before plummeting 98% to a mere $0.28 million in 2023 amid client churn, zero-COVID lockdowns, and regulatory headwinds, with a modest 413% rebound to $1.44 million in 2024. Aggressive cost-cutting slashed headcount 86% to 55 employees, stabilizing revenue per employee around $26,000 while gross margins held resilient at 41.2%, hinting at underlying SaaS scalability—but profitability remains elusive with persistent losses and negative cash flows.
Balance sheet improvements offer a cautious bright spot: debt plunged 91% to $0.31 million, flipping net debt to a $4.39 million cash surplus, bolstered by $6.23 million in working capital. Yet, massive share dilution—up 41,467% since 2019—has eroded book value per share 98% and fueled Nasdaq compliance scares via repeated reverse splits, leaving the stock at penny levels with compressed multiples (PS 0.66, PB 0.15). ROE and ROIC languish in negative territory, underscoring inefficient capital use and liquidity strains in a high-risk China exposure play.
Analysts flash extreme upside targets implying 121,000% potential, betting on AI product traction and economic stimulus, but absent insider buys and blank forecasts signal skepticism. With restructuring underway and revenue bottoming, IFBD sits at a potential inflection—yet dilution history, geopolitical tensions, and profitability distance demand vigilance. This high-volatility turnaround warrants scrutiny of upcoming earnings for sustainable momentum.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.